Fasenra on SilverScript Choice (S5601-056)
benralizumab
Covered, with prior authorization required.
Tier 5 (specialty tier). Quantity limit of 0.5 per 28 days.
$565.42
Patient pays / month, after deductible
$1,026.67
Patient pays / month, before the $615.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
FASENRA 10 mg/.5mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $2,261.68 for a month. Other covered strengths are listed below.
Prior authRequired on all 3 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 3 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| FASENRA 30 mg/mL Injection, Solution | 5 | $1,517.66 | PA · 1 per 28 days |
| FASENRA 10 mg/.5mL Injection, Solution | 5 | $565.42 | PA · 0.5 per 28 days |
| FASENRA 30 mg/mL Injection, Solution | 5 | $1,517.54 | PA · 1 per 28 days |
Other Asthma and COPD biologics on this plan
Verify with the plan before prescribing or filling. Member services: (866)235-5660. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5601-056